127 related articles for article (PubMed ID: 20567846)
1. RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection.
Chae YS; Kim JG; Sohn SK; Lee SJ; Kang BW; Moon JH; Park JY; Jeon SW; Bae HI; Choi GS; Jun SH
J Cancer Res Clin Oncol; 2011 Apr; 137(4):705-13. PubMed ID: 20567846
[TBL] [Abstract][Full Text] [Related]
2. Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patients.
Yao C; Li G; Cai M; Qian Y; Wang L; Xiao L; Thaiss F; Shi B
Cancer Biomark; 2017 Jul; 20(1):23-29. PubMed ID: 28759952
[TBL] [Abstract][Full Text] [Related]
3. Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment.
Qian J; Gu S; Wu Q; Zhao X; Wu W; Gao Z; Zhang W; Tan X; Wang H; Wang J; Fan W; Chen H; Han B; Lu D; Wei Q; Jin L
Chest; 2012 Sep; 142(3):680-689. PubMed ID: 22441531
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer.
Lee SJ; Kang BW; Chae YS; Kim HJ; Park SY; Park JS; Choi GS; Jeon HS; Lee WK; Kim JG
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S634-9. PubMed ID: 24770722
[TBL] [Abstract][Full Text] [Related]
5. IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Moon JH; Kang BW; Park JY; Jeon SW; Lee MH; Lim KH; Choi GS; Jun SH
Ann Oncol; 2010 Mar; 21(3):525-529. PubMed ID: 19759184
[TBL] [Abstract][Full Text] [Related]
6. Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP.
Chae YS; Kim JG; Sohn SK; Moon JH; Kim SN; Lee SJ; Park TI; Lee MH
Cancer Chemother Pharmacol; 2010 Feb; 65(3):571-7. PubMed ID: 19629486
[TBL] [Abstract][Full Text] [Related]
7. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
[TBL] [Abstract][Full Text] [Related]
8. TNF superfamily gene polymorphism as prognostic factor in early breast cancer.
Jung JH; Chae YS; Moon JH; Kang BW; Kim JG; Sohn SK; Park JY; Lee MH; Park HY
J Cancer Res Clin Oncol; 2010 May; 136(5):685-94. PubMed ID: 19890662
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin.
Kim JG; Chae YS; Sohn SK; Moon JH; Ryoo HM; Bae SH; Kum Y; Jeon SW; Lim KH; Kang BM; Park IJ; Choi GS; Jun SH
Cancer Chemother Pharmacol; 2009 Oct; 64(5):953-60. PubMed ID: 19219602
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer.
Lee HC; Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Jeon SW; Lee MH; Lim KH; Park JY; Choi GS; Jun SH
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1073-8. PubMed ID: 20044760
[TBL] [Abstract][Full Text] [Related]
12. MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.
Park JH; Kim NS; Park JY; Chae YS; Kim JG; Sohn SK; Moon JH; Kang BW; Ryoo HM; Bae SH; Choi GS; Jun SH
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1135-42. PubMed ID: 20091185
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphisms in CASP7 with risk of ischaemic stroke.
Zheng Z; Liu S; Wang C; Wang C; Tang D; Shi Y; Han X
Sci Rep; 2019 Dec; 9(1):18627. PubMed ID: 31819117
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the Caspase7 gene and the risk of lung cancer.
Lee WK; Kim JS; Kang HG; Cha SI; Kim DS; Hyun DS; Kam S; Kim CH; Jung TH; Park JY
Lung Cancer; 2009 Jul; 65(1):19-24. PubMed ID: 19058873
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS
Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012
[TBL] [Abstract][Full Text] [Related]
18. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
Zhang W; Gordon M; Press OA; Rhodes K; Vallböhmer D; Yang DY; Park D; Fazzone W; Schultheis A; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
Pharmacogenet Genomics; 2006 Jul; 16(7):475-83. PubMed ID: 16788380
[TBL] [Abstract][Full Text] [Related]
20. Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.
Hitre E; Budai B; Adleff V; Czeglédi F; Horváth Z; Gyergyay F; Lövey J; Kovács T; Orosz Z; Láng I; Kásler M; Kralovánszky J
Pharmacogenet Genomics; 2005 Oct; 15(10):723-30. PubMed ID: 16141798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
